Investor List:

Top Pharmaceuticals Pre-Seed Investors in Los Angeles / Southern California (19)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Mack Healy, Partner at KdT Ventures
Mack Healy
KdT Ventures·Partner
Sweet spot: $850K
Range: $700K - $1M
Investors in United States, Investors in Boston / New England, Investors in SF Bay Area (CA), Investors in San Diego (CA), Investors in Austin (TX), Investors in Houston (TX)
Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Analytics (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Health IT (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Material Science (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Seed), Investors in Analytics (Seed), Investors in AgTech (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Health IT (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Austin (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Avi Rosenbaum, Partner at Tectonic Capital
Avi Rosenbaum
Sweet spot: $250K
Range: $50K - $500K
Investors in New York City, Investors in Boston / New England, Investors in SF Bay Area (CA), Investors in San Diego (CA), Investors in Israel, Investors in Europe
Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in AgTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AgTech (Pre-seed), Investors in AI (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Manufacturing (Seed), Investors in Food and Beverage (Seed), Investors in Manufacturing (Seed), Investors in Food and Beverage (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Food and Beverage (Seed), Investors in Pharmaceuticals (Seed), Investors in Manufacturing (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Seed), Investors in AgTech (Seed), Investors in Manufacturing (Seed), Investors in Medical Devices (Seed), Investors in Food and Beverage (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Manufacturing (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in AI (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Series A), Investors in Food and Beverage (Series A), Investors in Food and Beverage (Series A), Investors in Manufacturing (Series A), Investors in Medical Devices (Series A), Investors in Food and Beverage (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series A), Investors in AgTech (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AgTech (Series A), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Food and Beverage (Series A), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Food and Beverage (Series A), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series A), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Manufacturing (Series A), Investors in Consumer Health (Series A), Investors in Food and Beverage (Series A), Investors in Health & Hospital Services (Series A), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series A), Investors in Israel (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Arye Lipman, General Partner at MarsBio
Arye Lipman
MarsBio·General Partner
Sweet spot: $250K
Range: $100K - $1M
Investors in Los Angeles (CA)
Investors in Chemicals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Impact (Pre-seed), Investors in Chemicals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Hardware (Pre-seed), Investors in BioTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in AgTech (Pre-seed), Investors in Impact (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Hardware (Pre-seed), Investors in BioTech (Pre-seed), Investors in Chemicals (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Impact (Seed), Investors in DeepTech (Seed), Investors in Chemicals (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in Hardware (Seed), Investors in BioTech (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in AgTech (Seed), Investors in Hardware (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Noah Berkson, Managing Partner at Candor Ventures
Noah Berkson
Candor Ventures·Managing Partner
Sweet spot: $200K
Range: $100K - $750K
Investors in Los Angeles (CA), Investors in Chicago (IL), Investors in Miami (FL), Investors in London
Investors in Human Capital/HRTech (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in AgTech (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in AgTech (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Insurance (Pre-seed), Investors in AgTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in FinTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in FinTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in AgTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Human Capital/HRTech (Seed), Investors in Sales & CRM (Seed), Investors in Pharmaceuticals (Seed), Investors in Human Capital/HRTech (Seed), Investors in Human Capital/HRTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Human Capital/HRTech (Seed), Investors in Insurance (Seed), Investors in Sales & CRM (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Seed), Investors in AgTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in Insurance (Seed), Investors in AgTech (Seed), Investors in Marketplaces (Seed), Investors in Real Estate/PropTech (Seed), Investors in Insurance (Seed), Investors in AgTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Seed), Investors in SaaS (Seed), Investors in Marketplaces (Seed), Investors in FinTech (Seed), Investors in Marketplaces (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in Marketplaces (Seed), Investors in Human Capital/HRTech (Seed), Investors in FinTech (Seed), Investors in Pharmaceuticals (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Sales & CRM (Seed), Investors in AgTech (Seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Seed), Investors in Marketplaces (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Midwest (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in London (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Andrew Brooks, Managing Partner at 111° West Capital
Andrew Brooks
111° West Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Santa Monica (CA)
Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Analytics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Los Angeles / Southern California (Other Lists)
Photo of Lan Jiang, Associate at Lux Capital
Lan Jiang
Lux Capital·Associate
Sweet spot: $10.0M
Range: $1M - $50.0M
Investors in Irvine (CA)
Photo of Randy Berholtz, Partner at Ventac Partners
Randy Berholtz
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Diego (CA)
Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in FinTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in FinTech (Pre-seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in FinTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Health IT (Series A), Investors in FinTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in FinTech (Series A), Investors in Los Angeles / Southern California (Other Lists)
Photo of Melody Kamrani, Partner at Empath Ventures
Melody Kamrani
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in Chemicals (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Chemicals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in FinTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Seed), Investors in Wellness & Fitness (Seed), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Wellness & Fitness (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Los Angeles / Southern California (Other Lists)